Disease/Infection News

RSS

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

IRIN examines HIV/AIDS response in Guinea-Bissau

IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut."

14 Dec 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Friday published Issue 206 of its "Global Fund Observer."

14 Dec 2012

Scientists discover new evidence about evolution of viruses

Scientists have discovered new evidence about the evolution of viruses, in work that will change our understanding about the control of infectious diseases such as winter flu.

14 Dec 2012

Continue support of GAVI Alliance and childhood disease prevention

"Last week a global health event took place in Dar Es Salaam, Tanzania, to foster greater political will and explore ways to accelerate results, innovation, sustainability, and equity in the field of immunization," Baroness Hollins, emeritus professor of psychiatry of disability at St George's University of London, writes in the BMJ Group Blog about the GAVI Partners Forum.

14 Dec 2012

New global disease burden data should inform global health spending

"On Dec. 14, the Lancet together with the Institute for Health Metrics and Evaluation [IHME] will release their study on global burden of disease, injuries and risk factors in 2010," Karl Hofmann, president and CEO of Population Services International, writes in a Devex opinion piece, adding, "These 'gold standard' data will quantify the world's health problems by examining statistics for 291 diseases and injuries and 67 different risk factors for 21 regions across three time periods -- 1990, 2005 and 2010."

14 Dec 2012

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

"What does it take to get to zero? While reflecting on the theme of this past World AIDS Day (Getting to zero, Zero new infections, Zero discrimination, Zero deaths), I asked myself this question," Lisa MacDonald, project manager at HealthBridge Foundation of Canada, writes in a Huffington Post Canada opinion piece.

14 Dec 2012

Meridian completes beta trials for two new illumigene molecular amplification tests

Meridian Bioscience, Inc. today announced that it has successfully completed beta trials for two new illumigene molecular amplification tests.

14 Dec 2012

HPV in women at or after menopause may represent an infection acquired years ago

A new study suggests that human papillomavirus (HPV) infection in women at or after menopause may represent an infection acquired years ago, and that HPV infections may exist below limits of detection after one to two years, similar to other viruses, such as varicella zoster, which can cause shingles.

14 Dec 2012

Some diplomats, U.N. observers express 'concerns' over U.N. appeal for Haitian cholera aid, Al Jazeera reports

Following U.N. Secretary-General Ban Ki-moon's announcement on Tuesday of a new initiative appealing for $2.2 billion over 10 years to fight cholera in Haiti and the Dominican Republic, Al Jazeera reports "there are concerns by some diplomats and U.N. observers that the funds necessary for the program would not be forthcoming from donors."

14 Dec 2012

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the publication of data from its first-in-human Phase 1 study of its NDV-3 vaccine program in the journal Vaccine.

13 Dec 2012

Fatal imbalance between global disease burden and drug development

Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.

13 Dec 2012

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

African sleeping sickness is an infectious disease that is widespread south of the Sahara Desert. Although the around sixty million people residing in tropical Africa run the risk of becoming infected with the disease every day, only around four million of them are monitored for the disease by disease-control authorities.

13 Dec 2012

Scientists identify new antibiotic substances in Russian Brown frog's skin

Following up on an ancient Russian way of keeping milk from going sour - by putting a frog in the bucket of milk - scientists have identified a wealth of new antibiotic substances in the skin of the Russian Brown frog. The study appears in ACS' Journal of Proteome Research.

13 Dec 2012

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Medivir AB, announced today the initiation of cohort 2 in the interferon-free phase II trial combining simeprevir with sofosbuvir (GS7977) based on a safety and efficacy planned interim analysis of cohort 1 including prior null responder HCV genotype 1 infected patients without advanced hepatic fibrosis.

13 Dec 2012

Lutheran Malaria Initiative holds advocacy day on Capitol Hill

In the U.N. Foundation Blog, Gretchen King, director of the Lutheran Malaria Initiative (LMI), examines the efforts of LMI to "mobiliz[e] U.S. Lutherans in the global effort to end malaria deaths in Africa."

13 Dec 2012

Reproductive Health Matters' supplement issue focuses on pregnancy decisions of HIV-positive women

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today publication of Reproductive Health Matters' 2012 supplement issue "Pregnancy decisions of women living with HIV".

13 Dec 2012

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls -- zero new HIV infections, zero discrimination and zero AIDS-related deaths -- are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

13 Dec 2012

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

Inexpensive, locally-produced ceramic cookstoves may produce less smoke than traditional indoor 3-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya.

13 Dec 2012

Study investigates different approaches to eradicate mosquito-borne diseases

A special issue of Pathogens and Global Health, published by Maney Publishing, investigates different approaches to eradicate mosquito-borne diseases. Mosquitoes can transmit a number of pathogenic diseases including dengue fever, yellow fever, and malaria.

13 Dec 2012

Disease/Infection News

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

IRIN examines HIV/AIDS response in Guinea-Bissau

Aidspan publishes new issue of 'Global Fund Observer'

Scientists discover new evidence about evolution of viruses

Continue support of GAVI Alliance and childhood disease prevention

New global disease burden data should inform global health spending

Gender inequality must be addressed to 'get to zero' in AIDS epidemic

Meridian completes beta trials for two new illumigene molecular amplification tests

HPV in women at or after menopause may represent an infection acquired years ago

Some diplomats, U.N. observers express 'concerns' over U.N. appeal for Haitian cholera aid, Al Jazeera reports

NovaDigm announces data from NDV-3 vaccine Phase 1 study on Candida and Staph infections

Fatal imbalance between global disease burden and drug development

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

Scientists identify new antibiotic substances in Russian Brown frog's skin

Medivir commences cohort 2 simeprevir and sofosbuvir phase II combination trial in HCV GT1

Lutheran Malaria Initiative holds advocacy day on Capitol Hill

Reproductive Health Matters' supplement issue focuses on pregnancy decisions of HIV-positive women

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

Ceramic cookstoves may not reduce risk of pneumonia in young rural Kenyan children

Study investigates different approaches to eradicate mosquito-borne diseases

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News